Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) generation via photodynamic activation is a biological and chemical process central to the mechanism of photodynamic therapy (PDT). In this context, ROS are produced when a photosensitizer molecule, upon absorption of specific wavelengths of light, transfers energy or electrons to molecular oxygen or other substrates. This results in the formation of cytotoxic ROS such as singlet oxygen, superoxide anion, hydrogen peroxide, and hydroxyl radicals that can damage cellular components and induce cell death. The process involves Type I (electron/hydrogen transfer) and Type II (energy transfer) mechanisms. PDT is utilized in cancer therapy and antimicrobial treatments, however it faces limitations in light penetration depth, hypoxia resistance and off-target effects.
Photosensitizer-mediated generation of reactive oxygen species (ROS) upon light activation, leading to oxidative damage and cell death.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive Oxygen Species Generation via Photodynamic Activation (ROS Generation via PDT).